𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Study of 13-cis-Retinoic Acid plus Interferon-α2a in Heavily Pretreated Squamous Carcinoma of the Cervix

✍ Scribed by Alton V. Hallum III; David S. Alberts; Scott M. Lippman; Lora Inclan; Glenn J. Shamdas; Joel M. Childers; Earl A. Surwit; Manuel Modiano; Kenneth D. Hatch

Book ID
115616468
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
264 KB
Volume
56
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

13-CIS retinoic acid and interferon-α ±
13-CIS retinoic acid and interferon-α ± irradiation in the treatment of squamous-cell carcinomas
✍ Wolfgang Hoffmann; Martina Schiebe; Peter Hirnle; Rainer Souchon; Michael Clemen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB 👁 1 views

Pre-clinical data indicate that retinoid/interferon combinations have significant activity in modulating malignant cell growth, differentiation and programmed cell death in different hematologic and solid tumor systems . Clinically, the combination of 13-cis retinoic acid (13cRA) and interferon-a (I

Phase II clinical trial of 13-cis-retino
Phase II clinical trial of 13-cis-retinoic acid and interferon-α-2a in patients with advanced esophageal carcinoma
✍ Peter C. Enzinger; David H. Ilson; Leonard B. Saltz; Lisa K. Martin; David P. Ke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## BACKGROUND. Interferon in combination with 5-fluorouracil has been shown to be active in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the esophagus. 13-cis-retinoic acid (CRA) has chemopreventive activity in SCC of the head and neck, and, in combination with interferon, has antitumo

A Phase II pilot trial of 13-cis retinoi
A Phase II pilot trial of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma
✍ Felix H. Brembeck; Klaus Schoppmeyer; Ursula Leupold; Costel Gornistu; Volker Ke 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## BACKGROUND. Advanced unresectable pancreatic adenocarcinoma has a dismal prognosis. The authors previously have shown that retinoic acid (RA) and interferon-␣ (IFN-␣) inhibit growth and induce differentiation in human pancreatic carcinoma cells in vitro and in vivo. The purpose of this trial wa